Signaling Pathways - P-glycoprotein (P-gp) - SGK - Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs) - P2X Receptors
清除全部
- B5410 AZ 10606120 dihydrochlorideTarget: P2X ReceptorsSummary: P2X7受体拮抗剂
- B1051 GSK 6503942 CitationTarget: SGKSummary: SGK1抑制剂
- A8549 LY335979 (Zosuquidar 3HCL)1 Citation中文名: 唑喹达三盐酸盐Target: P-glycoprotein (P-gp)Summary: Pgb(P糖蛋白)抑制剂
- A4506 DMOGTarget: Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs)Summary: 细胞通透的竞争性HIF-PH抑制剂
- A3956 ZosuquidarTarget: P-glycoprotein (P-gp)|Cytochrome P450 (CYP450)Summary: MDR调节剂
- A3859 Tariquidar methanesulfonate, hydrate中文名: 他立喹达二甲磺酸盐六水合物Target: P-glycoprotein (P-gp)Summary: P-糖蛋白抑制剂
- A3389 EMD6386834 CitationTarget: SGKSummary: SGK1 抑制剂
- A3384 Elacridar中文名: 依克立达Target: P-glycoprotein (P-gp)Summary: BCRP抑制剂
- A3136 A-740003Target: P2X ReceptorsSummary: P2X7受体拮抗剂
- A8208 Tariquidar2 Citation中文名: 他立喹达Target: P-glycoprotein (P-gp)Summary: P-糖蛋白抑制剂